Evolving strategies for the management of high-risk adult acute lymphoblastic leukemia

Affiliations

Comment

Renato Bassan. Haematologica. 2005 Oct.

. 2005 Oct;90(10):1299.

¹ Division of Hematology, Ospedali Riuniti, Bergamo, Italy. rbassan@ospedaliriuniti.bergamo.it

No abstract available

Comment on

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández-Rivas JM, Moreno MJ, del Potro E, Torm M, Rivas C, Besalduch J, Sanz MA, Ortega JJ; PETHEMA Group, Spain. Ribera JM, et al. Haematologica. 2005 Oct;90(10):1346-56. Haematologica. 2005. PMID: 16219571 Clinical Trial.